BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3230749)

  • 1. [A study of prevention of ejaculatory disturbance after retroperitoneal lymph node dissection in testicular tumor].
    Kihara K; Fukui I; Tari K; Oka K; Oshima H
    Nihon Hinyokika Gakkai Zasshi; 1988 Dec; 79(12):1982-90. PubMed ID: 3230749
    [No Abstract]   [Full Text] [Related]  

  • 2. Nerve-sparing retroperitoneal lymph node dissection for advanced testicular cancer after chemotherapy.
    Nonomura N; Nishimura K; Takaha N; Inoue H; Nomoto T; Mizutani Y; Nakao M; Okuyama A; Miki T
    Int J Urol; 2002 Oct; 9(10):539-44. PubMed ID: 12445231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual function after bilateral retroperitoneal lymph node dissection for nonseminomatous testicular cancer.
    Nijman JM; Schraffordt Koops H; Oldhoff J; Kremer J; Jager S
    Arch Androl; 1987; 18(3):255-67. PubMed ID: 3675073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders.
    Dimitropoulos K; Karatzas A; Papandreou C; Daliani D; Zachos I; Pisters LL; Tzortzis V
    Andrologia; 2016 May; 48(4):425-30. PubMed ID: 26268684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
    Coogan CL; Hejase MJ; Wahle GR; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1996 Nov; 156(5):1656-8. PubMed ID: 8863564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ejaculatory status and fertility rates after primary retroperitoneal lymph node dissection.
    Beck SD; Bey AL; Bihrle R; Foster RS
    J Urol; 2010 Nov; 184(5):2078-80. PubMed ID: 20850817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of ejaculation disorders after retroperitoneal lymph node dissection.
    Nijman JM; Jager S; Boer PW; Kremer J; Oldhoff J; Koops HS
    Cancer; 1982 Dec; 50(12):2967-71. PubMed ID: 7139590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-treatment fertility in patients with testicular cancer. I. Influence of retroperitoneal lymph node dissection on ejaculatory potency.
    Fosså SD; Ous S; Abyholm T; Loeb M
    Br J Urol; 1985 Apr; 57(2):204-9. PubMed ID: 2580586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of the management of post-chemotherapy retroperitoneal lymph node dissection-associated anejaculation.
    Hsiao W; Deveci S; Mulhall JP
    BJU Int; 2012 Oct; 110(8):1196-200. PubMed ID: 22233208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retroperitoneal lymph node dissection after chemotherapy.
    Winter C; Raman JD; Sheinfeld J; Albers P
    BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer.
    Subramanian VS; Nguyen CT; Stephenson AJ; Klein EA
    Urol Oncol; 2010; 28(5):504-9. PubMed ID: 19097812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.
    Stepanian S; Patel M; Porter J
    Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redefining the refined retroperitoneal lymph node dissection in testis cancer: a SWOT analysis of nonrandomized data.
    Garnick MB
    J Clin Oncol; 2007 Oct; 25(28):4337-8. PubMed ID: 17906195
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.
    Johnston P; Beck SD; Cheng L; Masterson TA; Bihrle R; Kesler K; Foster RS
    J Urol; 2013 Sep; 190(3):874-7. PubMed ID: 23517745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual function after high retroperitoneal lymphadenectomy.
    Kedia KR; Markland C; Fraley EE
    Urol Clin North Am; 1977 Oct; 4(3):523-8. PubMed ID: 565094
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of limited retroperitoneal lymphadenectomy in nonseminomatous germ cell tumors.
    Sherlag AP; O'Brien DP; Graham SD
    Urology; 1989 May; 33(5):355-7. PubMed ID: 2540584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modified lymphadenectomy in testicular tumor].
    Weissbach L
    Urologe A; 1992 Jul; 31(4):208. PubMed ID: 1514201
    [No Abstract]   [Full Text] [Related]  

  • 18. Postchemotherapy retroperitoneal lymph node dissection for testis cancer.
    Risk MC; Foster RS
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):95-106. PubMed ID: 21166514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
    Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
    Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
    Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.